Cancer chronotherapy

Journal of Pharmacy and Pharmacology

Volumn 51, Issue 8, 1999, Pages 891-898

  Lévi, Francis ^a  

^a HÔPITAL PAUL BROUSSE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; CISPLATIN; DOXORUBICIN; FLUOROURACIL; FOLINIC ACID; OXALIPLATIN; PIRARUBICIN;

ANTINEOPLASTIC ACTIVITY; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CELL METABOLISM; CELL PROLIFERATION; CHRONOTHERAPY; CIRCADIAN RHYTHM; CLINICAL TRIAL; COLORECTAL CANCER; COMPUTER PROGRAM; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG TOLERABILITY; HUMAN; HYDROCORTISONE BLOOD LEVEL; INFUSION PUMP; INOPERABLE CANCER; MAJOR CLINICAL STUDY; META ANALYSIS; MUCOSA INFLAMMATION; NONHODGKIN LYMPHOMA; OVARY CANCER; PHARMACOKINETICS; SENSORY NEUROPATHY; SURVIVAL RATE; SURVIVAL TIME; UTERINE CERVIX CANCER;

EID: 17144435741     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357991773302     Document Type: Conference Paper

References (48)

1. Benavides, M. (1991) Cancer Avance de l'Ovaire: Approche Chronobiologique comme Nouvelle Strategie du Traitement et de la Surveillance Clinique et Biologique. PhD Thesis, Universite Paris XI
2. Bertheault-Cvitkovic, F., Jami, A., Ithzaki, M., Brummer, P. D., Brienza, S., Adam, R., Kunstlinger, F., Bismuth, H., Misset, J. L., Lévi, F. (1996) Biweekly intensified ambulatory chronomodulated chemotherapy with oxaliplatin, 5-fluorouracil and folinic acid in patients with metastatic colorectal cancer. J. Clin. Oncol. 14: 2950-2958
3. Bjamason, G. A., Marsh, R., Chu, N. M., Kerr, I., Franssen, E. (1998) Phase II study of 5-fluorouracil (FU) and leucovorin LV) by a 14 day chronomodulated infusion in patients with metastatic colorectal cancer. Proc. Am. Soc. Clin. Oncol. 17: 275a
4. Brienza, S., Lévi, F., Valori, V. (1993) Intensified (every two weeks) chronotherapy with 5-fluorouracil (5-FU), folinic acid (FA) and oxaliplatin (L-OHP) in previously treated patients with metastatic colorectal cancer. Proc. Am. Soc. Clin. Oncol. 12: 197
5. Buchi, K. N., Moore, J. G., Hrushesky, W. J., Sothern, R. B., Rubin, N. H. (1991) Circadian rhythm of cellular proliferation in the human rectal mucosa. Gastroenterology 101: 410-415
6. Caussanel, J. P., Lévi, F., Brienza, S., Misset, J. L., Itzhaki, M., Adam, R., Milano, G., Hecquet, B., Mathe, G. (1990) Phase I trial of 5-day continuous venous infusion of oxaliplatin at circadian rhythm-modulated rate compared with constant rate. J. Natl Cancer Inst. 82: 1046-1050
7. th Intern. Conf. Chronopharm. Chronother., Amelia Island FL, July 5-9, Abstract VIIIb-4
8. Curé, H., Adenis, A., Tubiana-Mathieu, N., Ouabdesselam, R., Kwiatkowski, F., Perpoint, B., Coudert, B., Focan, C., Giachetti, S., Lévi, F., Chollet, P. (1998) Phase II trial of chronomodulated (CM) high dose 5-fluorouracil (5-FU) and I-folinic acid (1-FA) in patients with metastatic colorectal cancer (MCC). Proc. Am. Soc. Clin. Oncol. 17: 273a
9. Depres-Brummer, P., Metzger, G., Lévi, F. (1998) Pharmacologic restoration of suppressed temperature rhythms in rats with melatonin, melatonin receptor agonist S20242 or 8-hydroxy-2-(di- n-propylamino)tetralin (8-OH-DPAT). Eur. J. Pharmacol. 347: 57-66
10. Garcia-Sainz, M., Halberg, F. (1966) Mitotic rhythms in human cancer reevaluated by electronic computer programs. Evidence for chronopathology. J. Natl Cancer Inst. 37: 279-292
11. Garufi, C., Lévi, F., Aschelter, A. M., Pace, R., Giunta, S., Nistico, C., Galla, D. A., Silecchia, G. F., Franchi, F., Narduzzi, C., Terzoli, E. (1997) A phase I trial of five day chronomodulated infusion of 5-fluorouracil and 1-folinic acid in patients with metastatic colorectal cancer. Eur. J. Cancer 33: 1566-1571
12. Gautherie, M., Gros, C. (1977) Circadian rhythm alteration of skin temperature in breast cancer. Chronobiologia 4: 1-17
13. Green, C. (1998) How cells tell time. Trends Cell Biol. 8: 224-230
14. Harris, B., Song, R., Soong, S., Diasio, R. B. (1990) Relationship between dihydropyrimidine dehydrogenase activity and plasma 5-fluorouracil levels : evidence for circadian variation of plasma drug levels in cancer patients receiving 5-fluorouracil by protracted continuous infusion. Cancer Res. 50: 197-201
15. Hrushesky, W. (1985) Circadian timing of cancer chemotherapy. Science 228: 73-75
16. Klein, D. C., Moore, R. Y., Reppert, S. M. (1991) Suprachiasmatic Nucleus, the Mind's Clock. Oxford University Press, Oxford
17. Klevecz, R., Braly, P. (1991) Circadian and ultradian cytokinetic rhythms of spontaneous human cancer. Ann. N.Y. Acad. Sci. 618: 257-276
18. Klevecz, R., Shymko, R., Braly, P. (1987) Circadian gating of S phase in human ovarian cancer. Cancer Res. 47: 6267-6271
19. Lévi, F. (1997) Chronopharmacology of anticancer agents. In: Redfern, P. H., Lemmer, B. (eds) Physiology and Pharmacology of Biological Rhythms. Handbook of Experimental Pharmacology. Vol. 125, Springer-Verlag, Berlin, pp 299-331
20. Lévi, F., Benavides, M., Chevelle, C., Le Saunier, F., Bailleul, F., Misset, J. L., Regensberg, C., Vannetzel, J. M., Reinberg, A., Mathe, G. (1990) Chemotherapy of advanced ovarian cancer with 4′-O-tetrahydropyranyl adriamycin (THP) and cisplatin: a phase II trial with an evaluation of circadian timing and dose intensity. J. Clin. Oncol. 8: 705-714
21. Lévi, F., Misset, J. L., Brienza, S., Adam, R., Metzger, G., Itzakhi, M., Caussanel, J. P., Kunstlinger, F., Lecouturier, S., Descorps-Declere, A. (1992) A chronopharmacologic phase II clinical trial with 5-fluorouracil, folinic acid and oxaliplatin using an ambulatory multichannel programmable pump. High antitumor effectiveness against metastatic colorectal cancer. Cancer 69: 893-900
22. Lévi, F., Perpoint, B., Garufi, C., Focan, C., Chollet, P., Depres-Brummer, P., Zidani, R., Brienza, S., Itzhaki, M., Iacobelli, S. (1993) Oxaliplatin activity against metastatic colorectal cancer. A phase II study of 5-day continuous venous infusion at circadian rhythm modulated rate. Eur. J. Cancer 29A: 1280-1284
23. Lévi, F. A., Zidani, R., Vannetzel, J. M., Perpoint, B., Focan, C., Faggiuolo, R., Chollet, P., Garufi, C., Itzhaki, M., Dogliotti, L. (1994) Chronomodulated versus fixed infusion rate delivery of ambulatory chemotherapy with oxaliplatin, 5-fluorouracil and folinic acid in patients with colorectal cancer metastases. A randomized multiinstitutional trial. J. Natl Cancer Inst. 86: 1608-1617
24. Lévi, F., Soussan, A., Adam, R., Caussanel, J. P., Metzger, G., Jasmin, C., Bismuth, H., Smolensky, M., Misset, J. L. (1995) A phase I-II trial of five-day continuous intravenous infusion of 5-fluorouracil delivered at circadian rhythm modulated rate in patients with metastatic colorectal cancer. J. Infus. Chemother. 5: 153-158
25. Lévi, F., Zidani, R., Brienza, S., Dogliotti, L., Perpoint, B., Rotarski, M., Letourneau, Y., Llory, J. F., Chollet, P., Le Rol, A., Kanoui, A., Focan, C., Giachetti, S., Bertheault-Cvitkovic, F., Kunstlinger, F., Adam, R., Itzhaki, M., Jasmin, C., Misset, J. L. (1999) A multicenter evaluation of intensified ambulatory chronomodulated chemotherapy with oxaliplatin, fluorouracil and leucovorin as initial treatment of patients with metastatic colorectal cancer. Cancer 85: 2532-2540
26. Lévi, F., Zidani, R., Misset, J. L. (1997) Randomized multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer. Lancet 350: 681-686
27. Li, X. M., Metzger, G., Filipski, E., Boughattas, N., Lemaigre, G., Hecquet, B., Filipski, J., Lévi, F. (1997) Pharmacologic modulation of reduced glutathione (GSH) circadian rhythms by buthionine sulfoximine (BSO): relationship with cisplatin (CDDP) toxicity in mice. Toxicol. Appl. Pharmacol. 143: 281-290
28. Mansfield, C. M., Carabasi, R. A., Wells, W., Borman, K. (1973) Circadian rhythm in the skin temperature of normal and cancerous breasts. Intl J. Chronobiol. 1: 235-243
29. Mormont, C. (1998) Selection et Validation d'un Test Predictif de la Survie des Patients Atteints de Cancer Colorectal Metastase, Fonde sur l'Alteration du Systeme Circadien. PhD Thesis, Universite Paris XI
30. Mormont, M. C., Lévi, F. (1997) Circadian-system alterations during cancer processes: a review. Int. J. Cancer 70:241-247
31. Mormont, M. C., Bleuzen, P., Lellouch, J. (1997) Prognostic value of circadian rhythm assessment for survival of patients with metastatic colorectal cancer. Proc. 33rd Ann. Meeting Am. Soc. Clin. Oncol., May 17-20,1997, Denver, CO, U.S.A., Abstract number 956
32. Mormont, M. C., Giacchetti, S., Waterhouse, J. (1998a) Activity circadian rhythm as an independent prognostic factor of survival in patients (pts) with metastatic colorectal cancer (MCC). Proc. 34th Ann. Meeting Am. Soc. Clin. Oncol. Abstract number 1032
33. Mormont, M. C., Hecquet, B., Bogdan, A., Benavides, M., Touitou, Y., Lévi, F. (1998b) Non-invasive estimation of the circadian rhythm in serum cortisol in patients with ovarian or colorectal cancer. Int. J. Cancer 78: 421-424
34. Ohdo, S., Makinosumi, T., Ishizaki, T., Yukawa, E., Higuchi, S., Nakano, S., Ogawa, N. (1997) Cell cycle-dependent chronotoxicity of irinotecan hydrochloride in mice. J. Pharmacol. Exp. Ther. 283: 1383-1388
35. Plautz, J. D., Kaneko, M., Hall, J. C., Kay, S. A. (1997) Independent photoreceptive circadian clocks throughout Drosophila. Science 278: 1632-1635
36. Smaaland, R., Abrahamsen, J. F., Svardal, A. M., Lote, K., Ueland, P. M. (1992) DNA cell cycle distribution and glutathione (GSH) content according to circadian stage in bone marrow of cancer patients. Br. J. Cancer 66: 39-45
37. Smaaland, R., Lote, K., Sothern, R. B., Laerum, O. D. (1993) DNA synthesis and ploidy in non-Hodgkin's lymphomas demonstrate variation depending on circadian stage of cell sampling. Cancer Res. 53: 3129-3138
38. Smaaland, R., Laerum, O. D., Lote, K., Sletvold, O., Sothern, R. B., Bjerknes, R. (1991) DNA synthesis in human bone marrow is circadian stage dependent. Blood 77: 2603-2611
39. Tahti, E. (1956) Studies of the effect of X-irradiation on 24 hour variations in the mitotic activity in human malignant tumors. Acta Path. Microbiol. Scand. 117: 1-61
40. Tampellini, M., Filipski, E., Liu, X. H., Lemaigre, G., Li, X. M., Vrignaud, P., Francois, E., Bissery, M. C., Lévi, F. (1998) Docetaxel chronopharmacology in mice. Cancer Res. 58: 3896-3904
41. Tei, H., Okamura, H., Shigeyoshi, Y., Fukuhara, C., Ozawa, R., Hirose, M., Sakaki, Y. (1997) Circadian oscillation of a mammalian homologue of the Drosophila period gene. Nature 89: 512-516
42. Touitou, Y., Haus, E. (1992) Biological Rhythms in Clinical and Laboratory Medicine, Springer-Verlag, Berlin
43. Touitou, Y., Lévi, F., Bogdan, A., Benavides, M., Bailleul, F., Misset, J. L. (1995) Circadian desynchronization of blood variables in patients with metastatic breast cancer. Role of prognostic factors. J. Cancer Res. Clin. Oncol. 121:181-188
44. Touitou, Y., Bogdan, A., Lévi, F., Benavides, M., Auzeby, A. (1996) Disruption of the circadian patterns of serum cortisol in breast and ovarian cancer patients. Relationships with tumor marker antigens. Br. J. Cancer 74: 1248-1252
45. Vitaterna, M. H., King, D. P., Chang, A. M., Kornhauser, J. M., Lowrey, P. L., McDonald, J. D., Dove, W. F., Pinto, L. H., Turek, F. W., Takahashi, J. S. (1994) Mutagenesis and mapping of a mouse gene, clock, essential for circadian behavior. Science 264: 719-725
46. Voutilainen, A. (1953) Uber die 24-stunden-rhythmik der mitozfrequenz in malignen Tumoren. Acta Path. Microbiol. Scand. 99 (Suppl.): 1-104
47. Zagula-Mally, Z. W., Cardoso, S. S., Williams, D. (1979) Time point differences in skin mitotic activity of actinic keratoses and skin cancers. In: Rainberg, A., Halberg, F. (eds) Chronopharmacology, Pergamon Press, New York, pp 399-402
48. Zhang, R., Lu, Z., Liu, T., Soong, S. J., Diasio, R. B. (1993) Relationship between circadian-dependent toxicity of 5-fluorodeoxyuridine and circadian rhythms of pyrimidine enzymes: possible relevance to fluoropyrimidine chemotherapy. Cancer Res. 53: 2816-2822